Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health.
about
Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensationEfficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndromeThe Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A ReviewReview article: current and emerging therapies for functional dyspepsia.Treating irritable bowel syndrome: overview, perspective and future therapies.Opioids and the gut: pharmacology and current clinical experience.Drug management of visceral pain: concepts from basic research.Chronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study.Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Current and novel therapeutic options for irritable bowel syndrome management.The safety of novel drugs used to treat irritable bowel syndrome.Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia.Impaired drinking capacity in patients with functional dyspepsia: intragastric distribution and distal stomach volume.Caloric intake capacity as measured by a standard nutrient drink test helps to predict weight loss after bariatric surgery.Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia?
P2860
Q24644669-2DA635E1-63DB-4A95-8C97-E25027B12AADQ24684839-6374A2BD-7033-4F68-B785-4ECCD2A750BBQ26851158-EB256834-0D18-42A1-9EF2-CA60FA5570C8Q34553942-143CB5A9-3F05-40D8-B859-FC9A887FAE0CQ35047051-56C51C43-5BC2-4357-9009-D9427F82EF71Q35860904-9DE3F267-1326-4EC7-8503-E014EAE2A3AAQ35947915-FC370651-5C79-4F9B-997B-A594C07A4966Q36215519-DE400C0B-FD99-401A-917A-0962E0FD27F7Q37164063-350C4D6D-AE79-4F83-BDCC-91A2DDA29663Q37438547-5DEB7D2F-BCD7-40CB-9825-3FDD25129A48Q38199522-351C67FC-2BAC-4308-B2DE-9EB27828D074Q41979327-0D2081F0-61B5-4ACF-8DA2-D77277E64917Q46921543-EB945259-D3CE-4611-8BEE-D80DDCE12F4CQ47581433-67621C8D-3795-4E90-8D20-583C7DCF2F05Q51522986-53352D2B-7470-475C-BEB7-F9513549A8C4
P2860
Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Effects of asimadoline, a kapp ...... stprandial symptoms in health.
@en
Effects of asimadoline, a kapp ...... stprandial symptoms in health.
@nl
type
label
Effects of asimadoline, a kapp ...... stprandial symptoms in health.
@en
Effects of asimadoline, a kapp ...... stprandial symptoms in health.
@nl
prefLabel
Effects of asimadoline, a kapp ...... stprandial symptoms in health.
@en
Effects of asimadoline, a kapp ...... stprandial symptoms in health.
@nl
P2093
P2860
P1476
Effects of asimadoline, a kapp ...... stprandial symptoms in health.
@en
P2093
Camilleri M
Cremonini F
Delgado-Aros S
McKinzie S
P2860
P304
P356
10.1046/J.1365-2036.2003.01670.X
P407
P577
2003-09-01T00:00:00Z